Champions Oncology, Inc. ( CSBR) - Stock Earnings
CSBR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 14, 2026, midnight | — / — | — | — / — | — |
CSBR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 299000 USD | 15.0 million USD |
| 2025Q4 | -279000 USD | 16.6 million USD |
| 2026Q1 | -729000 USD | 13.8 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CSBR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -7.3 million USD | 50.2 million USD |
| 2025 | 4.7 million USD | 56.9 million USD |
| 2026 | -1.2 million USD | 59.4 million USD |
| 2026 Est. | — | — |
CSBR
Price: $5.09
52 week price:
Earnings Per Share: -0.08 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4300
Ebitda: -4.7 millionMarket Capitalization: 74.5 million